The BH3 Mimetic Obatoclax Accumulates in Lysosomes and Causes Their Alkalinization.

Obatoclax belongs to a class of compounds known as BH3 mimetics which function as antagonists of Bcl-2 family apoptosis regulators. It has undergone extensive preclinical and clinical evaluation as a cancer therapeutic. Despite this, it is clear that obatoclax has additional pharmacological effects...

Full description

Bibliographic Details
Main Authors: Vasileios A Stamelos, Natalie Fisher, Harnoor Bamrah, Carolyn Voisey, Joshua C Price, William E Farrell, Charles W Redman, Alan Richardson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4780728?pdf=render
_version_ 1818262393987268608
author Vasileios A Stamelos
Natalie Fisher
Harnoor Bamrah
Carolyn Voisey
Joshua C Price
William E Farrell
Charles W Redman
Alan Richardson
author_facet Vasileios A Stamelos
Natalie Fisher
Harnoor Bamrah
Carolyn Voisey
Joshua C Price
William E Farrell
Charles W Redman
Alan Richardson
author_sort Vasileios A Stamelos
collection DOAJ
description Obatoclax belongs to a class of compounds known as BH3 mimetics which function as antagonists of Bcl-2 family apoptosis regulators. It has undergone extensive preclinical and clinical evaluation as a cancer therapeutic. Despite this, it is clear that obatoclax has additional pharmacological effects that contribute to its cytotoxic activity. It has been claimed that obatoclax, either alone or in combination with other molecularly targeted therapeutics, induces an autophagic form of cell death. In addition, obatoclax has been shown to inhibit lysosomal function, but the mechanism of this has not been elucidated. We have evaluated the mechanism of action of obatoclax in eight ovarian cancer cell lines. Consistent with its function as a BH3 mimetic, obatoclax induced apoptosis in three cell lines. However, in the remaining cell lines another form of cell death was evident because caspase activation and PARP cleavage were not observed. Obatoclax also failed to show synergy with carboplatin and paclitaxel, chemotherapeutic agents which we have previously shown to be synergistic with authentic Bcl-2 family antagonists. Obatoclax induced a profound accumulation of LC-3 but knockdown of Atg-5 or beclin had only minor effects on the activity of obatoclax in cell growth assays suggesting that the inhibition of lysosomal function rather than stimulation of autophagy may play a more prominent role in these cells. To evaluate how obatoclax inhibits lysosomal function, confocal microscopy studies were conducted which demonstrated that obatoclax, which contains two basic pyrrole groups, accumulates in lysosomes. Studies using pH sensitive dyes demonstrated that obatoclax induced lysosomal alkalinization. Furthermore, obatoclax was synergistic in cell growth/survival assays with bafilomycin and chloroquine, two other drugs which cause lysosomal alkalinization. These studies explain, for the first time, how obatoclax inhibits lysosomal function and suggest that lysosomal alkalinization contributes to the cytotoxic activity of obatoclax.
first_indexed 2024-12-12T19:02:25Z
format Article
id doaj.art-fe841501bcc54322968b98bf7bd8bc13
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T19:02:25Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-fe841501bcc54322968b98bf7bd8bc132022-12-22T00:15:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01113e015069610.1371/journal.pone.0150696The BH3 Mimetic Obatoclax Accumulates in Lysosomes and Causes Their Alkalinization.Vasileios A StamelosNatalie FisherHarnoor BamrahCarolyn VoiseyJoshua C PriceWilliam E FarrellCharles W RedmanAlan RichardsonObatoclax belongs to a class of compounds known as BH3 mimetics which function as antagonists of Bcl-2 family apoptosis regulators. It has undergone extensive preclinical and clinical evaluation as a cancer therapeutic. Despite this, it is clear that obatoclax has additional pharmacological effects that contribute to its cytotoxic activity. It has been claimed that obatoclax, either alone or in combination with other molecularly targeted therapeutics, induces an autophagic form of cell death. In addition, obatoclax has been shown to inhibit lysosomal function, but the mechanism of this has not been elucidated. We have evaluated the mechanism of action of obatoclax in eight ovarian cancer cell lines. Consistent with its function as a BH3 mimetic, obatoclax induced apoptosis in three cell lines. However, in the remaining cell lines another form of cell death was evident because caspase activation and PARP cleavage were not observed. Obatoclax also failed to show synergy with carboplatin and paclitaxel, chemotherapeutic agents which we have previously shown to be synergistic with authentic Bcl-2 family antagonists. Obatoclax induced a profound accumulation of LC-3 but knockdown of Atg-5 or beclin had only minor effects on the activity of obatoclax in cell growth assays suggesting that the inhibition of lysosomal function rather than stimulation of autophagy may play a more prominent role in these cells. To evaluate how obatoclax inhibits lysosomal function, confocal microscopy studies were conducted which demonstrated that obatoclax, which contains two basic pyrrole groups, accumulates in lysosomes. Studies using pH sensitive dyes demonstrated that obatoclax induced lysosomal alkalinization. Furthermore, obatoclax was synergistic in cell growth/survival assays with bafilomycin and chloroquine, two other drugs which cause lysosomal alkalinization. These studies explain, for the first time, how obatoclax inhibits lysosomal function and suggest that lysosomal alkalinization contributes to the cytotoxic activity of obatoclax.http://europepmc.org/articles/PMC4780728?pdf=render
spellingShingle Vasileios A Stamelos
Natalie Fisher
Harnoor Bamrah
Carolyn Voisey
Joshua C Price
William E Farrell
Charles W Redman
Alan Richardson
The BH3 Mimetic Obatoclax Accumulates in Lysosomes and Causes Their Alkalinization.
PLoS ONE
title The BH3 Mimetic Obatoclax Accumulates in Lysosomes and Causes Their Alkalinization.
title_full The BH3 Mimetic Obatoclax Accumulates in Lysosomes and Causes Their Alkalinization.
title_fullStr The BH3 Mimetic Obatoclax Accumulates in Lysosomes and Causes Their Alkalinization.
title_full_unstemmed The BH3 Mimetic Obatoclax Accumulates in Lysosomes and Causes Their Alkalinization.
title_short The BH3 Mimetic Obatoclax Accumulates in Lysosomes and Causes Their Alkalinization.
title_sort bh3 mimetic obatoclax accumulates in lysosomes and causes their alkalinization
url http://europepmc.org/articles/PMC4780728?pdf=render
work_keys_str_mv AT vasileiosastamelos thebh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization
AT nataliefisher thebh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization
AT harnoorbamrah thebh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization
AT carolynvoisey thebh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization
AT joshuacprice thebh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization
AT williamefarrell thebh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization
AT charleswredman thebh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization
AT alanrichardson thebh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization
AT vasileiosastamelos bh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization
AT nataliefisher bh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization
AT harnoorbamrah bh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization
AT carolynvoisey bh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization
AT joshuacprice bh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization
AT williamefarrell bh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization
AT charleswredman bh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization
AT alanrichardson bh3mimeticobatoclaxaccumulatesinlysosomesandcausestheiralkalinization